The Global Health and Emerging Pathogens Institute is expanding the translational aspects of Mount Sinai's antimicrobial research by creating programs in vaccine, antiviral, and antimicrobial drug development.
The Institute, based in New York City, builds on Mount Sinai’s internationally recognized expertise in RNA virus research and encompasses ongoing research on the molecular pathogenesis of influenza, HIV, and dengue and Ebola viruses, as well as on hepatitis C. Read More
Adolfo García-Sastre, PhD, Professor of Microbiology, is Co-Director of the Global Health and Emerging Pathogens Institute and Principal Investigator for the Center for Research on Influenza Pathogenesis, an NIAID Center of Excellence for Influenza Research and Surveillance. Read More
Young Immunology Researchers Receive Prestigious Grant For Outstanding Discoveries
June 16, 2011 - Benjamin tenOever, PhD, and Julie Magarian Blander, PhD, each received a grant from the Burroughs Wellcome Fund for their pioneering work in the study of infectious diseases
2009 H1N1 Vaccine Protects Against 1918 Influenza Virus, Alleviating Bioterrorism Concerns
June 15, 2010 - Researchers at Mount Sinai School of Medicine have found that people vaccinated against H1N1 influenza may also be protected against 1918 Spanish influenza.